OTCMKTS:HEMA HemaCare (HEMA) Stock Price, News & Analysis $25.31 +0.15 (+0.60%) (As of 01/3/2020) Add Compare Share Share Today's Range$25.31▼$25.3150-Day Range$25.31▼$25.3152-Week Range$8.62▼$26.23Volume5,400 shsAverage Volume39,950 shsMarket Capitalization$346.52 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get HemaCare alerts: Email Address Ad True Gold RepublicChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a population of over 1.4 BILLION is “buying gold like there’s no tomorrow,” according to The New York Times. China, a rising global economic threat, aims to reduce its dependence on the US dollar… . Click here now to get your free 'De-Dollarization' Guide. About HemaCare Stock (OTCMKTS:HEMA)HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy. It offers human blood cellular components derived from peripheral blood, bone marrow, and cord blood; and a range of consulting services in standard operating procedure development, personnel training, and quality and regulatory compliance. The company's network of FDA-registered, GMP/GTP-compliant collection centers ensures donor materials available to customers, as well as for use within its isolation laboratory. The company has strategic partnership with Charles River Laboratories International Inc. for human immune system research. HemaCare Corporation was founded in 1978 and is headquartered in Northridge, California.Read More HEMA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HEMA Stock News HeadlinesJuly 19, 2024 | finance.yahoo.comGlobal Cell Freezing Media Market Size To Worth USD 387.5 Million By 2033 l CAGR Of 9.66%February 21, 2024 | msn.comDonors flock to blood centers following Union Station shootingSeptember 7, 2024 | Deal Maker (Ad)The solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.October 22, 2023 | investing.comHEMA Historical DataJuly 6, 2023 | finanznachrichten.dePrimary Cells Market worth $2.8 billion | MarketsandMarketsJune 22, 2023 | marketwatch.comThe worldwide Therapeutic Plasma Exchange industry is currently experiencing significant growth and expanding at a 13.6% CAGR from 2023 - 2030May 16, 2023 | marketwatch.comRegion-Wise Apheresis Machines Market Analysis Forecast 2023-2030May 14, 2023 | marketwatch.com2023 Apheresis Machines Market Price & News with Size Forecast 2030September 7, 2024 | Deal Maker (Ad)The solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.May 14, 2023 | marketwatch.comPeripheral Blood Market upto 2030May 9, 2023 | marketwatch.com2023 Bone Marrow Transplant Market: Trends and Forecast 2031 | A Detailed Sales Channel Analysis ReportMay 4, 2023 | marketwatch.comResearch Use Human Cells Market 2023 Size, Status and Global Outlook -Charles River, Lonza, Thermo Fisher Scientific, Sigma-AldrichMay 3, 2023 | marketwatch.comApheresis Equipment Market Size 2023, Industry Share, Growth, Trends, Revenue Analysis 2023-2030May 3, 2023 | marketwatch.comBone Marrow Transplant Market Growth Opportunities and Emerging Trends till 2031April 28, 2023 | marketwatch.comApheresis Devices Market Complete Overview till 2031April 15, 2023 | marketwatch.comGlobal Continuous Flow Apheresis Device Market Growth, Size and Manufacturers Analysis Research Report and Forecast 2023-2030 By VMReportsApril 13, 2023 | marketwatch.comPeripheral Blood Market Forecasted from 2023-2030April 10, 2023 | marketwatch.comNavigating the Pharmaceutical Sterility Testing Market Growth Outlook by market Trends and market size Using a 6.9% CAGR from 2023 - 2030See More Headlines Receive HEMA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for HemaCare and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Miscellaneous Health & Allied Services Sub-IndustryN/A Current SymbolOTCMKTS:HEMA CUSIP423498104 CIK801748 Webwww.hemagen.com Phone818-226-1968FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares13,691,000Free FloatN/AMarket Cap$346.52 million OptionableNot Optionable Beta1.47 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Peter C. van der Wal (Age 62)Pres, CEO & Director Ms. Rochelle J. Martel M.B.A.CPA, Chief Financial OfficerMs. Maria Pia MunizSr. VP of OperationsMr. Lou JulianoSr. VP of Global Sales & Bus. Devel.Dr. Dominic ClarkeGlobal Head of Cell TherapyKey CompetitorsPacific Health Care OrganizationOTCMKTS:PFHODCurative BiotechnologyOTCMKTS:CTYXBioRestorative TherapiesOTCMKTS:BRTXQLongboard PharmaceuticalsNASDAQ:LBPHPhreesiaNYSE:PHRView All Competitors HEMA Stock Analysis - Frequently Asked Questions How have HEMA shares performed this year? HemaCare's stock was trading at $25.31 on January 1st, 2024. Since then, HEMA stock has increased by 0.0% and is now trading at $25.31. View the best growth stocks for 2024 here. How do I buy shares of HemaCare? Shares of HEMA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of HemaCare own? Based on aggregate information from My MarketBeat watchlists, some other companies that HemaCare investors own include First Majestic Silver (AG), Warner Bros. Discovery (DISCA), Cognizant Technology Solutions (CTSH), Canadian Solar (CSIQ), CMC Materials (CCMP) and Athenex (ATNX). This page (OTCMKTS:HEMA) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HemaCare Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share HemaCare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
